2018 China Fundus Disease Forum and International Retinal Symposium was held in Qingdao, Shandong Province from March 28 to 31, 2018. The conference is an annual academic event in the field of fundus diseases in China, bringing together several Chinese and foreign ophthalmologists, who shared the new technologies and new knowledge in the field of ophthalmology from the perspectives of speech reports, case analysis, live surgery broadcast, etc., and showed the cutting-edge academic research for the experts and doctors of fundus diseases attending the conference. The conference set up several special reports, including keynote lectures by special guests, Sino-Japanese Forum on fundus diseases, discussion of difficult cases, vitreoretinal surgery, macular interface disease surgery, and new progress in fundus imaging, including special lectures on fundus diseases, paper speeches, case discussions and surgical video exchanges, which were rich and wonderful. More than 4,000 eye experts across the country shared the academic feast.
Diabetic retinopathy (DR) was also one of the key topics discussed at the conference. DR Is the most common microvascular complication in diabetic patients and the first irreversible blinding disease in working people. The Guideline for the Prevention and Treatment of Type 2 Diabetes in China (2017 edition) points out that the prevalence rate of DR Among diabetic patients in China is as high as 24.7-37.5%, there are 3-4 million patients with DR Blindness every year, and 90% of DR Blindness can be avoided through early detection and intervention, and early prevention is of great significance. Oxidative stress and inflammatory reaction caused by hyperglycemia and microcirculation disorder leading to ocular microvascular leakage are the main mechanisms of DR Occurrence and development. The mechanism of action of Xin-silver products is to reduce capillary permeability, anti-inflammation and anti-seepage, improve venous elasticity and tension, promote venous and lymphatic return, improve microcirculation, and resist oxygen free radicals. It can be seen that it is very beneficial for mild to moderate patients with non-proliferative diabetic retinopathy to take starsilver products for treatment and prevention on the basis of controlling metabolic abnormalities and intervening risk factors.
Ophthalmology is one of the main departments in the sales of Xingyin products. Participating in the national academic conference on fundus diseases is a good opportunity to enhance the corporate image and increase the popularity of Xingyin products. At this conference, the company set up a booth and sponsored 65 doctors from all over the country to attend, highlighting the company\'s efforts to increase academic promotion.